Home Cart 0 Sign in  
X

[ CAS No. 446-52-6 ]

{[proInfo.proName]} ,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
3d Animation Molecule Structure of 446-52-6
Chemical Structure| 446-52-6
Chemical Structure| 446-52-6
Structure of 446-52-6 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Bulk Inquiry Add To Cart

Quality Control of [ 446-52-6 ]

Related Doc. of [ 446-52-6 ]

Alternatived Products of [ 446-52-6 ]

Product Details of [ 446-52-6 ]

CAS No. :446-52-6 MDL No. :MFCD00003302
Formula : C7H5FO Boiling Point : -
Linear Structure Formula :- InChI Key :ZWDVQMVZZYIAHO-UHFFFAOYSA-N
M.W :124.11 Pubchem ID :67970
Synonyms :

Calculated chemistry of [ 446-52-6 ]

Physicochemical Properties

Num. heavy atoms : 9
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.0
Num. rotatable bonds : 1
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 31.79
TPSA : 17.07 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.78 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.52
Log Po/w (XLOGP3) : 1.8
Log Po/w (WLOGP) : 2.06
Log Po/w (MLOGP) : 1.88
Log Po/w (SILICOS-IT) : 2.42
Consensus Log Po/w : 1.94

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 2.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.17
Solubility : 0.838 mg/ml ; 0.00675 mol/l
Class : Soluble
Log S (Ali) : -1.78
Solubility : 2.07 mg/ml ; 0.0167 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.58
Solubility : 0.326 mg/ml ; 0.00262 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.0

Safety of [ 446-52-6 ]

Signal Word:Danger Class:3
Precautionary Statements:P501-P240-P210-P233-P243-P241-P242-P264-P280-P370+P378-P337+P313-P305+P351+P338-P362+P364-P303+P361+P353-P332+P313-P403+P235 UN#:1989
Hazard Statements:H225-H315-H319 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 446-52-6 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 446-52-6 ]
  • Downstream synthetic route of [ 446-52-6 ]

[ 446-52-6 ] Synthesis Path-Upstream   1~56

  • 1
  • [ 446-52-6 ]
  • [ 387-43-9 ]
Reference: [1] Canadian Journal of Chemistry, 2007, vol. 85, # 4, p. 283 - 292
  • 2
  • [ 446-52-6 ]
  • [ 17890-56-1 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2012, vol. 22, # 8, p. 2922 - 2926
  • 3
  • [ 2365-48-2 ]
  • [ 446-52-6 ]
  • [ 22913-24-2 ]
Reference: [1] ACS Medicinal Chemistry Letters, 2016, vol. 7, # 8, p. 751 - 756
[2] Bioorganic and Medicinal Chemistry Letters, 2005, vol. 15, # 12, p. 2998 - 3001
[3] Bioorganic and Medicinal Chemistry Letters, 2016, vol. 26, # 19, p. 4684 - 4686
  • 4
  • [ 446-52-6 ]
  • [ 399-68-8 ]
Reference: [1] Canadian Journal of Chemistry, 2007, vol. 85, # 4, p. 283 - 292
  • 5
  • [ 106-41-2 ]
  • [ 446-52-6 ]
  • [ 56341-31-2 ]
Reference: [1] Organic Letters, 2013, vol. 15, # 4, p. 928 - 931
  • 6
  • [ 446-52-6 ]
  • [ 348-32-3 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2011, vol. 19, # 4, p. 1550 - 1561
  • 7
  • [ 446-52-6 ]
  • [ 446-51-5 ]
  • [ 89-99-6 ]
Reference: [1] Organic Letters, 2002, vol. 4, # 12, p. 2055 - 2058
  • 8
  • [ 446-52-6 ]
  • [ 89-99-6 ]
Reference: [1] Journal of Medicinal Chemistry, 2006, vol. 49, # 21, p. 6197 - 6208
[2] Organic and Biomolecular Chemistry, 2016, vol. 14, # 39, p. 9306 - 9311
  • 9
  • [ 446-52-6 ]
  • [ 446-48-0 ]
Reference: [1] Tetrahedron Letters, 2000, vol. 41, # 27, p. 5161 - 5164
[2] European Journal of Organic Chemistry, 2017, vol. 2017, # 5, p. 996 - 1003
  • 10
  • [ 95-52-3 ]
  • [ 7726-95-6 ]
  • [ 446-48-0 ]
  • [ 446-51-5 ]
  • [ 446-52-6 ]
  • [ 445-29-4 ]
Reference: [1] Journal of the Chemical Society, 1926, p. 220
  • 11
  • [ 110-91-8 ]
  • [ 446-52-6 ]
  • [ 58028-76-5 ]
YieldReaction ConditionsOperation in experiment
63% at 125℃; for 2.5 h; Microwave irradiation Example 180: N-(l-Methyl-1H-pyrazol-4-yl)-1-(2-morpholinobenzyl)-1H-pyrazolo[3,4- d]pyrimidin-6-amine Step (i)A mixture of 2-fluorobenzaldehyde (0.5mL, 4.8mmol), morpholine (0.6mL, 1.5eq) and potassium carbonate (1.3g, 2eq) was heated in the microwave at 125°C for 2.5h. After evaporation, the residue was partitioned between water and DCM, the aqueous phase extracted with DCM. The combined organic phases were dried over sodium sulfate and concentrated in vacuo to afford 2-morpholinobenzaldehyde (0.57g, 63percent).
50.6% With N-ethyl-N,N-diisopropylamine In acetonitrile at 85℃; for 4 h; Cooling with ice To an ice-cooled and stirred solution of 9 (500 mg,1 mmol) in acetonitrile (2.5 mL), DIPEA (1 mmol) was added followed by morpholine (for 10a) (1 mmol) and heated at 85 °C for 4 h. It was cooled to room temperature and then concentrated. The residue was dissolved in ethyl acetate, washed with water followed by brine and then dried over anhydrous sodium sulphate. The solvent was removed under vacuum to get crude compound. The obtained crude material was purified over silica gel column (60–120 mesh) using gradient ethyl acetate/pet ether to give title compound as pale yellow solid. Compounds 10(b–e) were similarly synthesized. 2-Morpholinobenzaldehyde (10a) Pale yellow solid (0.39 g, 50.6 percent); mp: 84–86 °C. 1H-NMR (400 MHz, CDCl3): δ 2.85 (t, J = 10.00 Hz, 4H), 3.35 (t,J = 10.00 Hz, 4H), 7.12–7.17 (m, 2H), 7.52-7.56 (m, 1H),7.80–7.83 (m, 1H), 10.33 (s, 1H). IR (KBr, cm-1) 3067.2 (C–H, aromatic), 2960.2 (C–H, alkane), 2827.1 (C=O, aldehyde), 1332.6 (C–N, aromatic).
Reference: [1] Russian Chemical Bulletin, 2004, vol. 53, # 6, p. 1240 - 1247
[2] Synthesis, 2010, # 24, p. 4287 - 4299
[3] Patent: WO2011/48082, 2011, A1, . Location in patent: Page/Page column 160; 161
[4] Medicinal Chemistry Research, 2015, vol. 24, # 9, p. 3516 - 3528
[5] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1975, p. 1679 - 1682
[6] Chemical Communications, 2010, vol. 46, # 35, p. 6593 - 6595
[7] Patent: EP1688138, 2006, A1, . Location in patent: Page/Page column 86
[8] Tetrahedron, 2013, vol. 69, # 34, p. 7019 - 7025
[9] Dalton Transactions, 2014, vol. 43, # 24, p. 9098 - 9110
[10] Journal of Organic Chemistry, 2014, vol. 79, # 21, p. 10434 - 10446
  • 12
  • [ 446-52-6 ]
  • [ 699-99-0 ]
Reference: [1] Bulletin de la Societe Chimique de France, 1973, p. 3092 - 3095
  • 13
  • [ 446-52-6 ]
  • [ 61034-86-4 ]
Reference: [1] Organic and Biomolecular Chemistry, 2014, vol. 12, # 47, p. 9716 - 9719
  • 14
  • [ 446-52-6 ]
  • [ 271-44-3 ]
  • [ 95-52-3 ]
Reference: [1] Journal of Organic Chemistry, 2006, vol. 71, # 21, p. 8166 - 8172
  • 15
  • [ 446-52-6 ]
  • [ 326-62-5 ]
Reference: [1] Tetrahedron Letters, 2003, vol. 44, # 30, p. 5707 - 5710
  • 16
  • [ 141-82-2 ]
  • [ 446-52-6 ]
  • [ 451-69-4 ]
Reference: [1] Bioscience, Biotechnology and Biochemistry, 2001, vol. 65, # 1, p. 161 - 163
[2] Molecules, 2009, vol. 14, # 10, p. 4166 - 4179
[3] Bioorganic and Medicinal Chemistry, 2011, vol. 19, # 15, p. 4513 - 4519
[4] Bioorganic and Medicinal Chemistry, 2015, vol. 23, # 19, p. 6389 - 6403
  • 17
  • [ 108-24-7 ]
  • [ 446-52-6 ]
  • [ 451-69-4 ]
Reference: [1] Bulletin de la Societe Chimique de France, 1973, p. 3092 - 3095
  • 18
  • [ 446-52-6 ]
  • [ 1643-26-1 ]
Reference: [1] Bulletin de la Societe Chimique de France, 1973, p. 3092 - 3095
  • 19
  • [ 446-52-6 ]
  • [ 437-81-0 ]
Reference: [1] Journal of the American Chemical Society, 2018, vol. 140, # 8, p. 2789 - 2792
  • 20
  • [ 446-52-6 ]
  • [ 38226-10-7 ]
Reference: [1] Organic Letters, 2017, vol. 19, # 23, p. 6280 - 6283
  • 21
  • [ 446-52-6 ]
  • [ 27996-87-8 ]
Reference: [1] Journal of Organic Chemistry, 2011, vol. 76, # 19, p. 8088 - 8094
  • 22
  • [ 446-52-6 ]
  • [ 2836-82-0 ]
Reference: [1] Chimica Therapeutica, 1968, vol. 3, p. 313 - 320
[2] Patent: WO2017/29104, 2017, A1,
  • 23
  • [ 79-24-3 ]
  • [ 446-52-6 ]
  • [ 2836-82-0 ]
Reference: [1] Journal of Medicinal and Pharmaceutical Chemistry, 1961, vol. 3, p. 567 - 582
  • 24
  • [ 17696-73-0 ]
  • [ 446-52-6 ]
  • [ 5395-89-1 ]
YieldReaction ConditionsOperation in experiment
50% at 100℃; for 16 h; 2-fluorobenzaldehyde (12.4 g, 0.1 mol, 1 eq) and methanesulphinic acid (11.2 g, 0.11 mol, 1.1 EQ) were dissolved in DMSO (75 ml) and heated to 100°C for 16 h. The reaction mixture was cooled to room temperature and poured onto crushed ice (100 g). The product was collected by filtration and dried in a vacuum oven at 45°C for 16 h to give 2- (methylsulphonyl) benzaldehyde (9.2 g, 50percent) as a yellow SOLID. 8H (300 MHz, CDC13) 10.77 (1H, s, CHO), 8.18-8. 16 (1H, m, ArH), 8.10-8. 08 (1H, m, ArH), 7.83-7. 80 (2H, m, ArH) and 3.28 (3H, S, S02CH3) ; LCMS 6 min, Rt = 1. 93 min, (M++1) = 185. 1.
Reference: [1] Patent: WO2004/52858, 2004, A2, . Location in patent: Page 109
  • 25
  • [ 446-52-6 ]
  • [ 445-28-3 ]
  • [ 445-29-4 ]
YieldReaction ConditionsOperation in experiment
24%
Stage #1: at -33℃; for 1 h; Inert atmosphere
Stage #2: at -33℃; for 1 h; Inert atmosphere; Reflux
General procedure: Under an argon atmosphere, liquid NH3 (25 mL) was condensedin a two-neck round-bottom flask immersed in a dry ice coolingbath and equipped with a dry ice reflux condenser. Aldehyde(7.34 mmol) was added, and the resulting solution (or suspension)was stirred for 1 h. KMnO4 (7.34 mmol, 1.16 g) was added,the cooling bath was removed, and the reaction mixture wasstirred for another hour with gentle reflux of NH3. Na2SO3 (22.0mmol, 2.78 g) was added, the reflux condenser was removed,and the NH3 was allowed to evaporate spontaneously. The darkbrownresidue was treated with 6 M HCl (30 mL), and theresulting precipitate was filtered, washed with H2O (100 mL)and sat. aq NaHCO3 (20 mL). All products were recrystallizedfrom EtOH.
24%
Stage #1: at -33℃; for 1 h; Inert atmosphere
Stage #2: for 1 h; Inert atmosphere; Reflux
General procedure: Under an argon atmosphere, liquid NH3 (25 mL) was condensedin a two-neck round-bottom flask immersed in a dry ice coolingbath and equipped with a dry ice reflux condenser. Aldehyde (7.34 mmol) was added, and the resulting solution (or suspension)was stirred for 1 h. KMnO4 (7.34 mmol, 1.16 g) was added,the cooling bath was removed, and the reaction mixture wasstirred for another hour with gentle reflux of NH3. Na2SO3 (22.0mmol, 2.78 g) was added, the reflux condenser was removed,and the NH3 was allowed to evaporate spontaneously. The darkbrownresidue was treated with 6 M HCl (30 mL), and theresulting precipitate was filtered, washed with H2O (100 mL)and sat. aq NaHCO3 (20 mL). All products were recrystallizedfrom EtOH.
Reference: [1] Synlett, 2014, vol. 25, # 9,
[2] Synlett, 2015, vol. 26, # 1, p. 84 - 86
  • 26
  • [ 446-52-6 ]
  • [ 445-28-3 ]
Reference: [1] RSC Advances, 2016, vol. 6, # 43, p. 37093 - 37098
[2] Organometallics, 2012, vol. 31, # 17, p. 6482 - 6490
  • 27
  • [ 446-52-6 ]
  • [ 394-47-8 ]
  • [ 445-28-3 ]
Reference: [1] RSC Advances, 2013, vol. 3, # 17, p. 5889 - 5894
  • 28
  • [ 446-52-6 ]
  • [ 766-49-4 ]
Reference: [1] Journal of the American Chemical Society, 1963, vol. 85, p. 3492 - 3496
[2] Tetrahedron, 2017, vol. 73, # 33, p. 5023 - 5028
  • 29
  • [ 446-52-6 ]
  • [ 360575-28-6 ]
Reference: [1] Journal of the American Chemical Society, 2017, vol. 139, # 2, p. 888 - 896
  • 30
  • [ 446-52-6 ]
  • [ 1813-93-0 ]
Reference: [1] Collection of Czechoslovak Chemical Communications, 1964, vol. 29, p. 97 - 120
  • 31
  • [ 446-52-6 ]
  • [ 19883-78-4 ]
Reference: [1] Synthetic Communications, 2013, vol. 43, # 21, p. 2892 - 2897
[2] Tetrahedron, 2016, vol. 72, # 46, p. 7256 - 7262
  • 32
  • [ 446-52-6 ]
  • [ 18944-77-9 ]
  • [ 19883-78-4 ]
Reference: [1] Advanced Synthesis and Catalysis, 2017, vol. 359, # 9, p. 1570 - 1576
  • 33
  • [ 446-52-6 ]
  • [ 1479-24-9 ]
Reference: [1] RSC Advances, 2013, vol. 3, # 31, p. 12616 - 12620
  • 34
  • [ 446-52-6 ]
  • [ 50777-76-9 ]
Reference: [1] Zeitschrift fur Naturforschung - Section B Journal of Chemical Sciences, 1999, vol. 54, # 12, p. 1532 - 1542
  • 35
  • [ 593-51-1 ]
  • [ 446-52-6 ]
  • [ 399-30-4 ]
Reference: [1] Journal of the Chemical Society - Perkin Transactions 1, 1998, # 16, p. 2527 - 2531
[2] Patent: WO2016/101885, 2016, A1, . Location in patent: Paragraph 0227; 0228; 0229; 0230; 0231; 0232
  • 36
  • [ 1765-93-1 ]
  • [ 446-52-6 ]
  • [ 342-25-6 ]
YieldReaction ConditionsOperation in experiment
98% With potassium phosphate; palladium diacetate In water; methyl cyclohexane for 8 h; Reflux Method of the present embodiment provides a 2,4 ′-difluorobenzophenone and preparation method thereof, as follows: in a 1000 ml round bottom flask The bottle was added sequentially o-fluoro benzaldehyde 124 g of 4-fluorophenylboronic acid and 140 g of potassium phosphate, 106 grams, 1.12 g of palladium acetate, then adding 500 ml of methyl cyclohexane and 100 ml of water and heated to reflux for 8 hours., sequentially passes through filtering, layering, washing with water, removing the solvent to obtain the product., 2,4 '-difluorobenzophenone 214 g, 98percent yield.
Reference: [1] Patent: CN104230691, 2016, B, . Location in patent: Paragraph 0028-0029
  • 37
  • [ 110-89-4 ]
  • [ 446-52-6 ]
  • [ 34595-26-1 ]
YieldReaction ConditionsOperation in experiment
92% With potassium carbonate In DMF (N,N-dimethyl-formamide) at 130℃; for 3 h; To a solution of the aldehyde 3a (20 g, 161.1 mmol) in dry DMF (160 ml), piperidine(19.1 ml, 193.4 mmol, 1.2 eq) and potassium carbonate (26.73 g, 193.4 mmol, 1.2eq) were successively added. The suspension was heated at 130°C for 3 h. Thereaction mixture was then poured into cold water and. acidified with citric acid up to ,pH 5. The aqueous layer was extracted 3X with EtOAc and the combined organicextract was successively washed with water, saturated NaHCO3 and brine. Afterdrying the organic extract over MgSO4, filtration and concentration, the desired 2-piperidinobenzaldehyde 3b was isolated as a red oil (28.23 g, 92percent yield).
90.5% With potassium carbonate In DMF (N,N-dimethyl-formamide) for 6 h; Heating / reflux EXAMPLE 1 Preparation of o-piperidino benzaldehyde (8) [0033] A mixture of o-fluorobenzaldehyde (1.24 gm, 10 mmol), potassium carbonate (2.76 gm, 20 mmol), and piperidine (1.7 gm, 20 mmol) was refluxed in dry DMF for 6 hrs. After the completion of reaction DMF was distilled out at vaccum and 5 ml of water was added to the residue and extracted the product with ethyl acetate (10 ml.x.2). Organic layer was dried over sodium sulphate and evaporated the solvent to afford 1.8 gm of product (8) (90.5percent) [0034] 1HNMR CDCl3 (Spectrum 9): 1.68(m, 6H), 3.05(m, 4H), 7.05(m, 2H), 7.45(dd, 1H), 7.75(dd, 1H).
1.72 g With potassium carbonate In N,N-dimethyl-formamide at 110 - 150℃; for 23 h; (1) A suspension of the Compound 1 (1.05 mE), the Compound 2 (1.09 mE), and potassium carbonate (2.76 g) in N,N-dimethylformamide (10 mE) was stirred at 1100 C. for 5 hours, and stirred at 1500 C. for 18 hours. The reaction mixture was allowed to cool to room temperature, and then water and ethyl acetate were added thereto, and the resulting mixture was stirred, and extracted with ethyl acetate. The resulting organic layers were washed with water and saturated brine, dried, and concentrated under reduced pressure. The resulting residues were purified by silica gel column chromatography (hexane:ethyl acetate=99: 1 to 88:12) to give the Compound 3 (1.72 g) as a yellow liquid. MS (APCI): mlz 190 [M+H]
Reference: [1] Angewandte Chemie - International Edition, 2012, vol. 51, # 8, p. 1950 - 1953
[2] Heterocycles, 2008, vol. 75, # 4, p. 799 - 838
[3] Patent: WO2004/108673, 2004, A2, . Location in patent: Page 38-39
[4] Patent: US2004/192921, 2004, A1, . Location in patent: Page 4
[5] Russian Chemical Bulletin, 2004, vol. 53, # 6, p. 1240 - 1247
[6] Chemistry of Heterocyclic Compounds, 2007, vol. 43, # 1, p. 76 - 81
[7] Synthesis, 2010, # 24, p. 4287 - 4299
[8] Journal of Organic Chemistry, 1989, vol. 54, # 1, p. 199 - 209
[9] Patent: WO2004/101540, 2004, A2, . Location in patent: Page/Page column 11-13
[10] Journal of Organic Chemistry, 2009, vol. 74, # 19, p. 7464 - 7469
[11] Journal of Organic Chemistry, 2010, vol. 75, # 9, p. 2893 - 2902
[12] Organic and Biomolecular Chemistry, 2010, vol. 8, # 18, p. 4077 - 4079
[13] Chemical Communications, 2010, vol. 46, # 35, p. 6593 - 6595
[14] Journal of Organic Chemistry, 2011, vol. 76, # 1, p. 342 - 345
[15] Chinese Chemical Letters, 2012, vol. 23, # 4, p. 395 - 398
[16] Tetrahedron, 2013, vol. 69, # 34, p. 7019 - 7025
[17] Dalton Transactions, 2014, vol. 43, # 24, p. 9098 - 9110
[18] Chemistry - A European Journal, 2015, vol. 21, # 4, p. 1632 - 1636
[19] Journal of Organic Chemistry, 2014, vol. 79, # 21, p. 10434 - 10446
[20] Organic Letters, 2017, vol. 19, # 7, p. 1566 - 1569
[21] Patent: US2018/258076, 2018, A1, . Location in patent: Paragraph 0496
  • 38
  • [ 288-13-1 ]
  • [ 446-52-6 ]
  • [ 138479-47-7 ]
Reference: [1] Australian Journal of Chemistry, 1991, vol. 44, # 8, p. 1097 - 1114
[2] Journal of the American Chemical Society, 2011, vol. 133, # 39, p. 15244 - 15247
[3] Angewandte Chemie - International Edition, 2012, vol. 51, # 11, p. 2690 - 2694
  • 39
  • [ 288-88-0 ]
  • [ 446-52-6 ]
  • [ 138479-53-5 ]
Reference: [1] Australian Journal of Chemistry, 1991, vol. 44, # 8, p. 1097 - 1114
  • 40
  • [ 109-01-3 ]
  • [ 446-52-6 ]
  • [ 85803-62-9 ]
YieldReaction ConditionsOperation in experiment
100% With potassium carbonate In water for 18 h; Heating / reflux PREPARATION 57; 2-(4-Methylpiperazin-1-v0benzaldehyde.2-Fluorobenzaldehyde (20.0 mL, 189.9 mmol), 1-methylpiperazine (33.0 mL, 297.7 mmol) and potassium carbonate (40.0 g, 289.4 mmol) in water (200 mL) were refluxed for 18h. After cooling, the mixture was extracted with EtOAc (2X 150 mL). These extracts were washed with brine, dried over MgSO4 and concentrated to give PP57 (38.6 g, 100percent) as an orange oil which had: NMR (CDCI3) δ 10.10 (s, 1 H), 7.77 (dd, J = 7.9, 1.7 Hz, 1 H), 7.51-7.48 (sym. mult., 1 H), 7.10-7.06 (m, 2H), 3.11 (t, J = 4.6 Hz, 4H), 2.63 (br s, 4H), 2.36 (s, 3H).
96% With potassium carbonate In water Example 1
2-(4-Methyl-1-piperazinyl)benzaldehyde
Potassium carbonate (8.3 g, 60 mmol) and 1-methylpiperazine (7.2 g, 72 mmol) were dissolved in 40 mL of water and then 2-fluorobenzaldehyde (5.0 g, 40 mmol) was added.
The mixture was heated at reflux (100-104° C.) under a nitrogen atmosphere for 22.5 hours when HPLC showed that the reaction was complete.
The solution was cooled to 20-25° C. and then extracted with methylene chloride (2*40 mL).
The methylene chloride extracts were combined, washed with water (2*50 mL), and then concentrated at reduced pressure to a yellow oil (7.8 g, 96percent yield).
1H NMR (CDCl3) showed that the yellow oil was essentially pure title compound and the 1H NMR spectrum was consistent with literature values (Walters et al., Synthesis, 1987: 641).
13C NMR (CDCl3) δ 191.70, 135.25, 129.94, 128.84, 122.84, 119.23, 55.34, 54.20, and 46.33.
54.8% With N-ethyl-N,N-diisopropylamine In acetonitrile at 85℃; for 4 h; Cooling with ice General procedure: To an ice-cooled and stirred solution of 9 (500 mg,1 mmol) in acetonitrile (2.5 mL), DIPEA (1 mmol) was added followed by morpholine (for 10a) (1 mmol) and heated at 85 °C for 4 h. It was cooled to room temperature and then concentrated. The residue was dissolved in ethyl acetate, washed with water followed by brine and then dried over anhydrous sodium sulphate. The solvent was removed under vacuum to get crude compound. The obtained crude material was purified over silica gel column (60–120 mesh) using gradient ethyl acetate/pet ether to give title compound as pale yellow solid. Compounds 10(b–e) were similarly synthesized.
Reference: [1] Patent: WO2006/48727, 2006, A1, . Location in patent: Page/Page column 83
[2] Patent: US2003/87914, 2003, A1,
[3] Russian Chemical Bulletin, 2004, vol. 53, # 6, p. 1240 - 1247
[4] Chemical Communications, 2017, vol. 53, # 75, p. 10448 - 10451
[5] Synthesis, 1987, # 7, p. 641 - 645
[6] Medicinal Chemistry Research, 2015, vol. 24, # 9, p. 3516 - 3528
[7] Journal of medicinal chemistry, 1983, vol. 26, # 8, p. 1116 - 1122
[8] Bioorganic and Medicinal Chemistry, 2006, vol. 14, # 8, p. 2498 - 2506
[9] Patent: US2004/254196, 2004, A1, . Location in patent: Page 9
[10] Patent: WO2005/90300, 2005, A1, . Location in patent: Page/Page column 30
  • 41
  • [ 2759-28-6 ]
  • [ 446-52-6 ]
  • [ 112253-26-6 ]
YieldReaction ConditionsOperation in experiment
89% With potassium carbonate In 1,4-dioxane; water for 24 h; Heating / reflux Example 3: Synthesis of 1-[4-(1-methoxy-1-methyl-ethyl)-phenvn-3-(2-piperazin- 1-yl-bertzvD-pyrrolidin-2-one (compound 12): EPO <DP n="24"/>12A mixture of 25 g of benzylpiperazine (1) and 10 g of 2-fluorobenzaldehyde (2) were allowed to react in refluxing dioxane/water (1 :2, 90 mL total volume) for 24 hours in the presence of 17 g K2CO3. The resultant reaction mixture was allowed to cool to room temperature, was extracted with methylene chloride and the organic layer was then washed with water, 5percent hydrochloric acid, brine, and was then dried over magnesium sulfate, was filtered, and the solvent was removed in vacuo. Purification by silica gel chromatography (5:1 hexanes-ethyl acetate) afforded 20 g of the benzaldehyde 3 in 89percent yield; MS (AP/CI) observed: 281.1 (M+H)+ (100percent). The benzaldehyde 3 (8 g) was subsequently allowed to react with 7.3 g of 1-acetyl-pyrrolidin-2-one (4) in the presence of 4.6 g of NaH (60percent in mineral oil) at O0C for 1 hour followed by warming to room temperature and stirring for 2 hours. After quenching carefully with methanol at 0 0C, the solvent was removed in vacuo, the residue was diluted with water, was extracted with methylene chloride and the organic extracts were washed with brine and were dried over magnesium sulfate and were filtered. The solvent was removed in vacuo and the residue was purified by silica gel chromatography (40:1 chloroform-methanol) to provide 7.9g of 3-[2-(4-benzyl-piperazin-1-yl)-benzylidene]- pyrrolidin-2-one (5) in 80percent yield; MS (AP/CI) observed: 348.1 (M+H)+, 100percent. Hydrogenation of 6.3 g of 5 with 1.5 g of Pd/C in 100 mL of methanol under 50 p.s.i. of pressure at 600C provided 3.8 g (82percent yield) of 3-(2-piperazin-1-yl-benzyl)-pyrrolidin-2-one (6) following filtration, removal of solvent in vacuo, and purification by silica gel chromatography (30:1 :0.3 chloroform-methanol-ammonium hydroxide); MS (AP/CI) observed: 260.1 (M+H)+, 100percent.3-(2-Piperazin-1-yl-benzyl)-pyrrolidin-2-one (6) (1.2 grams) was subsequently allowed to react with 1.27 g of 1-bromo-4-(1-methoxy-1-methyl-ethyl)-benzene (11) in the presence of 0.041 grams of N,N'-dimethylethylenediamine, 0.088 g of CuI and 0.96 grams of K2CO3 in toluene (6 mL) at 110 °C for 17 hours to provide 1.2 grams of the racemate 1-[4-(1-methoxy- 1-methyl-ethyl)-phenyl]-3-(2-piperazin-1-yl-benzyl)-pyrrolidin-2-one (12) (64percent yield) following silica gel chromatography (40:1 :0.5 chloroform-methanol-ammonium hydroxide); MS (AP/CI) observed: 408.2 (M+H)+.
Reference: [1] Patent: WO2006/75226, 2006, A1, . Location in patent: Page/Page column 23
[2] Synthesis, 1987, # 7, p. 641 - 645
  • 42
  • [ 446-52-6 ]
  • [ 52721-69-4 ]
Reference: [1] Journal of Medicinal Chemistry, 1992, vol. 35, # 16, p. 2970 - 2978
  • 43
  • [ 446-52-6 ]
  • [ 117752-04-2 ]
Reference: [1] Journal of the American Chemical Society, 2018, vol. 140, # 8, p. 2789 - 2792
  • 44
  • [ 446-52-6 ]
  • [ 96516-29-9 ]
Reference: [1] Journal of Organic Chemistry, 1995, vol. 60, # 22, p. 7348 - 7350
  • 45
  • [ 141-82-2 ]
  • [ 446-52-6 ]
  • [ 117391-49-8 ]
YieldReaction ConditionsOperation in experiment
76% With ammonium formate In ethanol for 7 h; Reflux General procedure: To a solution of malonic acid (1.04g, 10mmol), ammonium formate (1.26g, 20mmol) in ethanol (50ml) was added aromatic aldehyde (10mmol). The resulting mixture was then refluxed for 7h. The reaction mixture was allowed to cool to room temperature and filtrated to yield the crude product. The crude product was further purified by recrystallization (95percent ethanol) to provide the product as a white solid.
Reference: [1] European Journal of Medicinal Chemistry, 2018, vol. 143, p. 402 - 418
[2] Advanced Synthesis and Catalysis, 2010, vol. 352, # 2-3, p. 395 - 406
[3] Advanced Synthesis and Catalysis, 2017, vol. 359, # 9, p. 1570 - 1576
[4] ACS Medicinal Chemistry Letters, 2014, vol. 5, # 11, p. 1207 - 1212
[5] Journal of Organic Chemistry, 2009, vol. 74, # 23, p. 9152 - 9157
[6] Bulletin de la Societe Chimique de France, 1987, # 6, p. 1079 - 1083
[7] Tetrahedron Letters, 2005, vol. 46, # 3, p. 427 - 430
[8] Bioorganic and Medicinal Chemistry Letters, 2005, vol. 15, # 16, p. 3685 - 3690
  • 46
  • [ 67-56-1 ]
  • [ 1816-92-8 ]
  • [ 446-52-6 ]
  • [ 113162-36-0 ]
Reference: [1] Canadian Journal of Chemistry, 2007, vol. 85, # 4, p. 283 - 292
  • 47
  • [ 1816-92-8 ]
  • [ 446-52-6 ]
  • [ 113162-36-0 ]
Reference: [1] Nucleosides, Nucleotides and Nucleic Acids, 2007, vol. 26, # 8-9, p. 869 - 871
  • 48
  • [ 75-24-1 ]
  • [ 446-52-6 ]
  • [ 171032-87-4 ]
  • [ 162427-79-4 ]
Reference: [1] Angewandte Chemie - International Edition, 2005, vol. 44, # 15, p. 2232 - 2234
  • 49
  • [ 544-97-8 ]
  • [ 446-52-6 ]
  • [ 171032-87-4 ]
  • [ 162427-79-4 ]
Reference: [1] Organic Letters, 2007, vol. 9, # 10, p. 1927 - 1929
  • 50
  • [ 75-16-1 ]
  • [ 446-52-6 ]
  • [ 171032-87-4 ]
  • [ 162427-79-4 ]
Reference: [1] Tetrahedron Letters, 2007, vol. 48, # 17, p. 2989 - 2991
  • 51
  • [ 446-52-6 ]
  • [ 93777-26-5 ]
YieldReaction ConditionsOperation in experiment
88% With potassium bromate; sulfuric acid In water at 90℃; Example three: equipped with electric stirring, thermometer, Dropping funnel and condenser tube reactor was added 65percent aqueous sulfuric acid 500ml, Potassium bromate 167 g (1 mol), 124.1 g (1 mol) of o-fluorobenzaldehyde was added dropwise thereto, 90 ° C for 2-3 hours, to the system by adding water 1000ml, Extraction with methyl tert-butyl ether, The organic phase was washed with aqueous sodium sulfite, dried over anhydrous sodium sulfate and concentrated by filtration to remove methyl tert-butyl ether to give a brown-red oil. Vacuum distillation collected 63-65 ° C / 3mmHg fraction 178g, Yield 88percent, content 97percent.
Reference: [1] Patent: CN105884591, 2016, A, . Location in patent: Paragraph 0008; 0009; 0010; 0011
  • 52
  • [ 446-52-6 ]
  • [ 74-88-4 ]
  • [ 198633-76-0 ]
Reference: [1] Patent: US6063789, 2000, A,
  • 53
  • [ 93777-26-5 ]
  • [ 446-52-6 ]
  • [ 374538-01-9 ]
Reference: [1] Tetrahedron, 2002, vol. 58, # 9, p. 1657 - 1666
  • 54
  • [ 446-52-6 ]
  • [ 57260-71-6 ]
  • [ 174855-57-3 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2003, vol. 13, # 21, p. 3793 - 3796
[2] Bioorganic and Medicinal Chemistry Letters, 2004, vol. 14, # 17, p. 4417 - 4423
[3] Journal of Medicinal Chemistry, 2004, vol. 47, # 27, p. 6821 - 6830
[4] Journal of Organic Chemistry, 2005, vol. 70, # 22, p. 8924 - 8931
[5] Synthesis, 2010, # 24, p. 4287 - 4299
[6] Bioorganic and Medicinal Chemistry Letters, 2004, vol. 14, # 22, p. 5605 - 5609
[7] Bioorganic and Medicinal Chemistry Letters, 2008, vol. 18, # 17, p. 4817 - 4822
[8] Bioorganic and Medicinal Chemistry Letters, 2012, vol. 22, # 14, p. 4599 - 4604
  • 55
  • [ 110-85-0 ]
  • [ 446-52-6 ]
  • [ 736991-52-9 ]
YieldReaction ConditionsOperation in experiment
49.4% With potassium carbonate In N,N-dimethyl-formamide at 130℃; for 6 h; Inert atmosphere 50 ml round-bottom flask by adding 55A (1.0g, 8 . 1mmol), N, N-dimethylformamide (15 ml) to dissolve, then adding piperazine (836 mg, 9 . 7mmol) and K2CO3(1.68g, 12 . 2mmol), 130 °C reaction under 6h. After cooling to room temperature, diluted with water, ethyl acetate extraction, the combined organic phase dried with anhydrous sodium sulfate, concentrated after the silica gel column chromatography (petroleum ether: ethyl acetate = 5:1; dichloromethane: methanol =10:1) separation to obtain compound 55B (760 mg, yield 49.4percent).
Reference: [1] Patent: CN105777632, 2016, A, . Location in patent: Paragraph 0481; 0482; 0483
  • 56
  • [ 446-52-6 ]
  • [ 1323140-60-8 ]
Reference: [1] European Journal of Medicinal Chemistry, 2015, vol. 99, # 1, p. 82 - 91
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 446-52-6 ]

Fluorinated Building Blocks

Chemical Structure| 146137-80-6

[ 146137-80-6 ]

2-Fluoro-4-methylbenzaldehyde

Similarity: 0.97

Chemical Structure| 886762-64-7

[ 886762-64-7 ]

2-Fluoro-3-methylbenzaldehyde

Similarity: 0.97

Chemical Structure| 1550-35-2

[ 1550-35-2 ]

2,4-Difluorobenzaldehyde

Similarity: 0.97

Chemical Structure| 135427-08-6

[ 135427-08-6 ]

4-Fluoro-3-methylbenzaldehyde

Similarity: 0.97

Chemical Structure| 847502-88-9

[ 847502-88-9 ]

2,4-Difluoro-3-methylbenzaldehyde

Similarity: 0.95

Aryls

Chemical Structure| 146137-80-6

[ 146137-80-6 ]

2-Fluoro-4-methylbenzaldehyde

Similarity: 0.97

Chemical Structure| 886762-64-7

[ 886762-64-7 ]

2-Fluoro-3-methylbenzaldehyde

Similarity: 0.97

Chemical Structure| 1550-35-2

[ 1550-35-2 ]

2,4-Difluorobenzaldehyde

Similarity: 0.97

Chemical Structure| 135427-08-6

[ 135427-08-6 ]

4-Fluoro-3-methylbenzaldehyde

Similarity: 0.97

Chemical Structure| 847502-88-9

[ 847502-88-9 ]

2,4-Difluoro-3-methylbenzaldehyde

Similarity: 0.95

Aldehydes

Chemical Structure| 146137-80-6

[ 146137-80-6 ]

2-Fluoro-4-methylbenzaldehyde

Similarity: 0.97

Chemical Structure| 886762-64-7

[ 886762-64-7 ]

2-Fluoro-3-methylbenzaldehyde

Similarity: 0.97

Chemical Structure| 1550-35-2

[ 1550-35-2 ]

2,4-Difluorobenzaldehyde

Similarity: 0.97

Chemical Structure| 135427-08-6

[ 135427-08-6 ]

4-Fluoro-3-methylbenzaldehyde

Similarity: 0.97

Chemical Structure| 847502-88-9

[ 847502-88-9 ]

2,4-Difluoro-3-methylbenzaldehyde

Similarity: 0.95